Market research

FRNM Freenome, Inc. Common stock

NASDAQ USD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market cap: 1B
P/E ratio: Not available
Analyst target: 18
Dividend yield: Not available
Beta: 0.35

Loading price history…

Profile

Company facts

Exchange: NASDAQ
Currency: USD
Sector: Healthcare
Industry: Diagnostics & Research
ISIN: US35661P1003
Market cap: 1B
P/E ratio: Not available
Analyst target: 18
Dividend yield: Not available
Beta: 0.35

About

About Freenome, Inc. Common stock

Freenome, Inc. operates as a biotechnology company in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops blood-based tests, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.

Visit company website

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about FRNM.

FRNM Freenome, Inc. Common stock

Price & volume

Company facts

About Freenome, Inc. Common stock

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet